{
    "patient": {
        "Name": "Susan Barton",
        "DateOfBirth": "1934-06-10",
        "Sex": "Male",
        "Diagnosis": "Invasive ductal carcinoma",
        "BodyPart": "Breast",
        "Physician": "Dr. Elizabeth Wolfe",
        "TreatingInstitution": "Ellis Inc"
    },
    "specimen": {
        "Tumor specimen": {
            "source": "Breast",
            "CollectedDate": "2024-03-28",
            "ReceivedDate": "2024-03-28",
            "TumorPercentage": "77%"
        },
        "Normal specimen": {
            "source": "Blood",
            "CollectedDate": "2024-03-29",
            "ReceivedDate": "2024-03-30"
        }
    },
    "genomic variants": {
        "Somatic - Potentially Actionable": [
            {
                "Gene": "MET",
                "DNA Alteration": "c.3209T>G",
                "GeneMutation": "p.I639L Frameshift-LOF",
                "VariantAlleleFraction": "4.03%"
            },
            {
                "Gene": "MAP2K2",
                "DNA Alteration": "c.383C>T",
                "GeneMutation": "p.P128L Stopgain-LOF",
                "VariantAlleleFraction": "13.41%"
            },
            {
                "Gene": "PAX5",
                "DNA Alteration": "c.239C>G",
                "GeneMutation": "p.A322T Frameshift-LOF",
                "VariantAlleleFraction": "8.64%"
            },
            {
                "Gene": "SDHB",
                "DNA Alteration": "c.487T>C",
                "GeneMutation": "p.S163P Nonsense-GOF",
                "VariantAlleleFraction": "20.88%"
            }
        ],
        "Somatic - Biologically Relevant": [
            {
                "Gene": "SIX1",
                "DNA Alteration": "c.530A>G",
                "GeneMutation": "p.S163P Nonsense-LOF",
                "VariantAlleleFraction": "6.19%"
            },
            {
                "Gene": "SDHA",
                "DNA Alteration": "c.1660C>T",
                "GeneMutation": "p.S163P Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "11.74%"
            }
        ],
        "Germline - Pathogenic": [],
        "Pertinent Negatives": [
            "MSH2",
            "FGFR2"
        ]
    },
    "immunotherapy markers": [
        {
            "marker_name": "Tumor Mutational Burden",
            "TmbValue": "27 m/Mb",
            "Tmbpercentile": "90%",
            "Status type": "Microsatellite Instability Status",
            "statusvalue": "High"
        }
    ],
    "FDA-Approved Therapies": {
        "Current Diagnosis": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ],
        "Other Indications": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ]
    }
}